Weissella bacteria-derived nanovesicle and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- MD HEALTHCARE INC
- Publication Date
- 2021-07-30
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to nanovesicles derived from bacteria of the genus Weissella and uses thereof, and more particularly, to a method for preventing, reducing or treating inflammation using nanovesicles derived from bacteria of the genus Weissella. Composition of diseases.
[0002] This application claims priority and benefit to Korean Patent Applications 10-2018-0158621 and 10-2019-0132136 filed at the Korean Intellectual Property Office on December 10, 2018 and October 23, 2019, respectively, the specifications and accompanying All content disclosed in the figures is incorporated in this application. Background technique
[0003] Since the beginning of the 21st century, acute infectious diseases, which were considered epidemic diseases in the past, have become less important, while inflammatory diseases accompanied by immune dysfunction caused by disharmony between humans and microbiomes have become Major diseases change disease patterns....